Nature-Inspired Pathogen and Cancer Protein Covalent Inhibitors: From Plants and Other Natural Sources to Drug
1Institute of Biostructures and Bioimaging, Italian National Research Council (IBB-CNR), Via P. Castellino 111, 80131 Naples, Italy.
Nature-inspired covalent inhibitors offer targeted therapeutic potential. This review highlights natural compounds from fungi, marine life, bacteria, and plants, detailing their mechanisms against pathogens and cancer for future drug development.
Area of Science:
- Medicinal Chemistry
- Natural Products Chemistry
- Drug Discovery
Background:
- Nature is a rich source of diverse bioactive compounds for therapeutic development.
- Covalent inhibitors, which form bonds with targets, show promise for selective and sustained activity.
- Nature-inspired covalent inhibitors are gaining attention for anti-infective and anticancer applications.
Purpose of the Study:
- To review natural covalent inhibitors from various sources (fungi, marine organisms, bacteria, plants).
- To elucidate the molecular mechanisms of action against pathogens and cancer targets.
- To discuss advancements in synthetic modification and optimization for drug development.
Main Methods:
- Literature review of natural products with covalent inhibitory activity.
- Analysis of molecular mechanisms and structure-activity relationships.
- Exploration of synthetic strategies and optimization approaches.
Main Results:
- Identification of key structural motifs enabling covalent interactions in natural compounds.
- Demonstration of efficacy against diverse pathogens and cancer cell lines.
- Highlighting the potential of natural scaffolds for targeted covalent inhibition.
Conclusions:
- Natural covalent inhibitors represent a promising foundation for novel anti-infective and anticancer therapeutics.
- Understanding their mechanisms and structural features is crucial for drug design.
- Further research can bridge natural product discovery with modern drug development pipelines.
More Related Videos
10:58Protein WISDOM: A Workbench for In silico De novo Design of BioMolecules
Published on: July 25, 2013
10:33Development of Inhibitors of Protein-protein Interactions through REPLACE: Application to the Design and Development Non-ATP Competitive CDK Inhibitors
Published on: October 26, 2015
Related Concept Videos
Drug Discovery: Overview
Protein Networks
These interactions can be represented through maps depicting protein-protein interaction networks, represented as nodes and edges. Nodes are circles that are representative of a protein,...
Combination Therapies and Personalized Medicine
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
Targeted Cancer Therapies
There are several types of targeted therapies against...
Targets for Drug Action: Overview
Receptors are either membrane-spanning or intracellular proteins, which upon binding a ligand, get activated and transmit the signal downstream to elicit a response. Drugs bind receptors, either mimicking the action of endogenous ligands or blocking the receptor activity to bring about a modified response. Nearly 35% of approved drugs target the G...
The Intrinsic Apoptotic Pathway
